{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:49:19Z","timestamp":1794584959700,"version":"4.9.1"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1245\/s10434-025-18057-3","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T12:35:40Z","timestamp":1758026140000},"page":"8582-8604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Postmastectomy Radiation Therapy: An ASTRO\/ASCO\/SSO Clinical Practice Guideline"],"prefix":"10.1245","volume":"32","author":[{"given":"Rachel B.","family":"Jimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes D.","family":"Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Matsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Reyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian E.","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Schellhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kekoa","family":"Taparra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef H.","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Zellars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen C.","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"18057_CR1","unstructured":"Institute of Medicine (US). Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. In: Graham RMM, Miller Wolman D, Steinberg E, eds. Clinical Practice Guidelines We Can Trust. National Academies Press; 2011."},{"key":"18057_CR2","unstructured":"Institute of Medicine (US). Committee on Standards for Systematic Reviews of Comparative Effectiveness. In: Eden J LL, Berg A, Morton S, eds. Finding What Works In Health Care: Standards for Systematic Reviews. National Academies Press; 2011."},{"key":"18057_CR3","unstructured":"Ferlay JEM, Lam F, Laversanne M, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2024. Accessed March 21, 2024; https:\/\/gco.iarc.who.int\/today."},{"key":"18057_CR4","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"McGale P, Taylor C, Correa C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127\u201335.","journal-title":"Lancet"},{"key":"18057_CR5","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.prro.2016.08.009","volume":"6","author":"A Recht","year":"2016","unstructured":"Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Pract Radiat Oncol. 2016;6:e219\u201334.","journal-title":"Pract Radiat Oncol"},{"key":"18057_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2022.03.008","volume":"170","author":"M Overgaard","year":"2022","unstructured":"Overgaard M, Nielsen HM, Tramm T, et al. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiother Oncol. 2022;170:4\u201313.","journal-title":"Radiother Oncol"},{"key":"18057_CR7","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2005.02.8738","volume":"24","author":"HM Nielsen","year":"2006","unstructured":"Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24:2268\u201375.","journal-title":"J Clin Oncol"},{"key":"18057_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2006.04.006","volume":"79","author":"HM Nielsen","year":"2006","unstructured":"Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Loco-regional recurrence after mastectomy in high-risk breast cancer\u2014risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol. 2006;79:147\u201355.","journal-title":"Radiother Oncol"},{"key":"18057_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djh297","volume":"97","author":"J Ragaz","year":"2005","unstructured":"Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116\u201326.","journal-title":"J Natl Cancer Inst"},{"key":"18057_CR10","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Radiotherapy to regional nodes in early breast cancer: An individual patient data meta-analysis of 14 324 women in 16 trials. Lancet. 2023;402:1991-2003."},{"key":"18057_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2011.07.007","volume":"100","author":"J Wang","year":"2011","unstructured":"Wang J, Shi M, Ling R, et al. Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial. Radiother Oncol. 2011;100:200\u20134.","journal-title":"Radiother Oncol"},{"key":"18057_CR12","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","volume":"21","author":"PM Poortmans","year":"2020","unstructured":"Poortmans PM, Weltens C, Fortpied C, et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial. Lancet Oncol. 2020;21:1602\u201310.","journal-title":"Lancet Oncol"},{"key":"18057_CR13","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Moran MS, Huo Q, Yang Q, Haffty BG. Post-mastectomy radiotherapy for breast cancer patients with t1\u2013t2 and 1\u20133 positive lymph nodes: a meta-analysis. PLOS One. 2013;8:e81765.","journal-title":"PLOS One"},{"key":"18057_CR14","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/cncr.34352","volume":"128","author":"SMC Sittenfeld","year":"2022","unstructured":"Sittenfeld SMC, Zabor EC, Hamilton SN, et al. A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1\u20132N1 breast cancer. Cancer. 2022;128:3057\u201366.","journal-title":"Cancer"},{"key":"18057_CR15","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mds118","volume":"23","author":"P Karlsson","year":"2012","unstructured":"Karlsson P, Cole BF, Chua BH, et al. Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an international breast cancer study group report. Ann Oncol. 2012;23:2852\u20138.","journal-title":"Ann Oncol"},{"key":"18057_CR16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087\u2013106.","journal-title":"Lancet"},{"key":"18057_CR17","doi-asserted-by":"crossref","unstructured":"Kunkler I. Does postmastectomy radiotherapy in 'intermediate-risk' breast cancer impact overall survival? 10-year results of the BIG 204 MRC SUPREMO randomised trial. GS2-03; SESS-3537. San Antonio Breast Cancer Symposium; 2024.","DOI":"10.1158\/1557-3265.SABCS24-GS2-03"},{"key":"18057_CR18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10549-021-06341-1","volume":"189","author":"SZ Lim","year":"2021","unstructured":"Lim SZ, Kusumawidjaja G, Mohd Ishak HM, et al. Outcomes of stage I and II breast cancer with nodal micrometastases treated with mastectomy without axillary therapy. Breast Cancer Res Treat. 2021;189:837\u201343.","journal-title":"Breast Cancer Res Treat"},{"key":"18057_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2008.04.014","volume":"90","author":"M Kyndi","year":"2009","unstructured":"Kyndi M, Overgaard M, Nielsen HM, Sorensen FB, Knudsen H, Overgaard J. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol. 2009;90:74\u20139.","journal-title":"Radiother Oncol"},{"key":"18057_CR20","volume":"13","author":"X Rao","year":"2024","unstructured":"Rao X, Wang X, Jin K, et al. Outcomes with and without postmas-tectomy radiotherapy for pT3N0-1M0 breast cancer: an institutional experience. Cancer Med. 2024;13:e6927.","journal-title":"Cancer Med"},{"key":"18057_CR21","volume":"32","author":"R Zhao","year":"2022","unstructured":"Zhao R, He W, Guan X. Benefits of post-mastectomy radiation for T4N0M0 breast cancer patients: a SEER Database study. Cancer Treat Res Commun. 2022;32:100586.","journal-title":"Cancer Treat Res Commun"},{"key":"18057_CR22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","volume":"337","author":"M Overgaard","year":"1997","unstructured":"Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949\u201355.","journal-title":"N Engl J Med"},{"key":"18057_CR23","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","volume":"353","author":"M Overgaard","year":"1999","unstructured":"Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641\u20138.","journal-title":"Lancet"},{"key":"18057_CR24","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1200\/JCO.2006.06.9054","volume":"24","author":"AG Taghian","year":"2006","unstructured":"Taghian AG, Jeong JH, Mamounas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol. 2006;24:3927\u201332.","journal-title":"J Clin Oncol"},{"key":"18057_CR25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/cncr.23611","volume":"113","author":"R McCammon","year":"2008","unstructured":"McCammon R, Finlayson C, Schwer A, Rabinovitch R. Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a surveillance, epidemiology, and end results database analysis. Cancer. 2008;113:683\u20139.","journal-title":"Cancer"},{"key":"18057_CR26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/COC.0b013e31825d529b","volume":"36","author":"W Yan","year":"2013","unstructured":"Yan W, Christos P, Nori D, Chao KS, Ravi A. Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status\/race\/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database. Am J Clin Oncol. 2013;36:552\u20137.","journal-title":"Am J Clin Oncol"},{"key":"18057_CR27","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2004.01.042","volume":"22","author":"A Taghian","year":"2004","unstructured":"Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22:4247\u201354.","journal-title":"J Clin Oncol"},{"key":"18057_CR28","doi-asserted-by":"crossref","first-page":"BSR20181853","DOI":"10.1042\/BSR20181853","volume":"39","author":"G Peng","year":"2019","unstructured":"Peng G, Zhou Z, Jiang M, Yang F. Can a subgroup at high risk for LRR be identified from T1\u20132 breast cancer with negative lymph nodes after mastectomy? A meta-analysis. Biosci Rep. 2019;39:BSR20181853.","journal-title":"Biosci Rep"},{"key":"18057_CR29","doi-asserted-by":"crossref","first-page":"P2185","DOI":"10.1016\/j.ejso.2020.08.015","volume":"46","author":"J Bundred","year":"2020","unstructured":"Bundred J. Do surgical margins matter after mastectomy? A systematic review. Eur J Surg Oncol. 2020;46:P2185\u201394.","journal-title":"Eur J Surg Oncol"},{"key":"18057_CR30","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.ijrobp.2007.05.029","volume":"69","author":"AK Garg","year":"2007","unstructured":"Garg AK, Oh JL, Oswald MJ, et al. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys. 2007;69:1478\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2007.01.023","volume":"68","author":"SE McGuire","year":"2007","unstructured":"McGuire SE, Gonzalez-Angulo AM, Huang EH, et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1004\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR32","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1245\/s10434-019-07635-x","volume":"26","author":"D Krug","year":"2019","unstructured":"Krug D, Lederer B, Seither F, et al. Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials. Ann Surg Oncol. 2019;26:3892\u2013901.","journal-title":"Ann Surg Oncol"},{"key":"18057_CR33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1186\/s12885-021-08423-1","volume":"21","author":"K Wang","year":"2021","unstructured":"Wang K, Jin X, Wang W, Yu X, Huang J. The role of postmas-tectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis. BMC Cancer. 2021;21:728.","journal-title":"BMC Cancer"},{"key":"18057_CR34","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1016\/j.clbc.2022.07.003","volume":"22","author":"S Murchison","year":"2022","unstructured":"Murchison S, Nichol A, Speers C, et al. Locoregional recurrence and survival outcomes in breast cancer treated with modern neoadjuvant chemotherapy: a contemporary population-based analysis. Clin Breast Cancer. 2022;22:e773\u201387.","journal-title":"Clin Breast Cancer"},{"key":"18057_CR35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2019.04.038","volume":"105","author":"BG Haffty","year":"2019","unstructured":"Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC. Impact of radiation on locoregional control in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: results from ACO-SOG Z1071 clinical trial. Int J Radiat Oncol Biol Phys. 2019;105:174\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/COC.0b013e31829d1eb8","volume":"38","author":"D Arsenault","year":"2015","unstructured":"Arsenault D, Hurley J, Takita C, et al. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy. Am J Clin Oncol. 2015;38:348\u201352.","journal-title":"Am J Clin Oncol"},{"key":"18057_CR37","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ijrobp.2020.06.028","volume":"108","author":"Z Huang","year":"2020","unstructured":"Huang Z, Zhu L, Huang XB, et al. Postmastectomy radiation therapy based on pathologic nodal status in clinical node-positive stage II to III breast cancer treated with neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2020;108:1030\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR38","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","volume":"30","author":"EP Mamounas","year":"2012","unstructured":"Mamounas EP, Anderson SJ, Dignam JJ, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol. 2012;30:3960\u20136.","journal-title":"J Clin Oncol"},{"key":"18057_CR39","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109668","volume":"184","author":"O Saifi","year":"2023","unstructured":"Saifi O, Bachir B, Panoff J, Poortmans P, Zeidan YH. Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: pooled analysis of TRYPHAENA and NeoSphere trials. Radiother Oncol. 2023;184:109668.","journal-title":"Radiother Oncol"},{"key":"18057_CR40","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1245\/s10434-020-09136-8","volume":"28","author":"A Crown","year":"2021","unstructured":"Crown A, Gonen M, Le T, Morrow M. Does failure to achieve pathologic complete response with neoadjuvant chemotherapy identify node-negative patients who would benefit from postmastectomy radiation or regional nodal irradiation? Ann Surg Oncol. 2021;28:1328\u201335.","journal-title":"Ann Surg Oncol"},{"key":"18057_CR41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2015.11.005","volume":"94","author":"BG Haffty","year":"2016","unstructured":"Haffty BG, McCall LM, Ballman KV, et al. Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: results from ACOSOG Z1071 (Alliance). Int J Radiat Oncol Biol Phys. 2016;94:493\u2013502.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR42","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4143\/crt.2022.998","volume":"55","author":"D Kim","year":"2023","unstructured":"Kim D, Kim JH, Kim IA, Chang JH, Shin KH. Impact of postmas-tectomy radiation therapy on breast cancer patients according to pathologic nodal status after modern neoadjuvant chemotherapy. Cancer Res Treat. 2023;55:592\u2013602.","journal-title":"Cancer Res Treat"},{"key":"18057_CR43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2022.03.007","volume":"113","author":"RB Mailhot Vega","year":"2022","unstructured":"Mailhot Vega RB, Wang S, Brooks ED, et al. Evaluating regional nodal irradiation allocation and association with oncologic outcomes in NSABP B-18, B-27, B-40, and B-41. Int J Radiat Oncol Biol Phys. 2022;113:542\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2010.06.027","volume":"81","author":"H Nagar","year":"2011","unstructured":"Nagar H, Mittendorf EA, Strom EA, et al. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer. Int JRadiat Oncol Biol Phys. 2011;81:782\u20137.","journal-title":"Int JRadiat Oncol Biol Phys"},{"key":"18057_CR45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2013.09.021","volume":"88","author":"SJ Shim","year":"2014","unstructured":"Shim SJ, Park W, Huh SJ, et al. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12\u201305). Int J Radiat Oncol Biol Phys. 2014;88:65\u201372.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clbc.2014.09.012","volume":"15","author":"H Nagar","year":"2015","unstructured":"Nagar H, Boothe D, Ginter PS, et al. Disease-free survival according to the use of postmastectomy radiation therapy after neoadju-vant chemotherapy. Clin Breast Cancer. 2015;15:128\u201334.","journal-title":"Clin Breast Cancer"},{"key":"18057_CR47","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijrobp.2010.12.054","volume":"82","author":"R Le Scodan","year":"2012","unstructured":"Le Scodan R, Selz J, Stevens D, et al. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys. 2012;82:e1\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR48","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382:810\u201321.","journal-title":"N Engl J Med"},{"key":"18057_CR49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","volume":"13","author":"L Gianni","year":"2012","unstructured":"Gianni L, Pienkowski T, Im YH, et al. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial. Lancet Oncol. 2012;13:25\u201332.","journal-title":"Lancet Oncol"},{"key":"18057_CR50","doi-asserted-by":"crossref","first-page":"02","DOI":"10.1158\/1538-7445.AM2024-2","volume":"84","author":"E Mamounas","year":"2024","unstructured":"Mamounas E, Bandos H, White J, et al. Loco-Regional irradiation in patients with biopsy-proven axillary node involvement at presentation who become pathologically node-negative after neoadjuvant chemotherapy: primary outcomes of NRG oncology\/NSABP B-51\/RTOG 1304. Cancer Res. 2024;84:02\u20137.","journal-title":"Cancer Res"},{"key":"18057_CR51","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1470-2045(22)00482-X","volume":"23","author":"SR de Wild","year":"2022","unstructured":"de Wild SR, de Munck L, Simons JM, et al. De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010\u201303): 5-year follow-up results of a Dutch, prospective, registry study. Lancet Oncol. 2022;23:1201\u201310.","journal-title":"Lancet Oncol"},{"key":"18057_CR52","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/719175","volume":"2014","author":"I Meattini","year":"2014","unstructured":"Meattini I, Cecchini S, Di Cataldo V, et al. Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. Biomed Res Int. 2014;2014:719175.","journal-title":"Biomed Res Int"},{"key":"18057_CR53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2017.04.012","volume":"79","author":"P Gillon","year":"2017","unstructured":"Gillon P, Touati N, Breton-Callu C, Slaets L, Cameron D, Bonnefoi H. Factors predictive of locoregional recurrence following neoadju-vant chemotherapy in patients with large operable or locally advanced breast cancer: an analysis of the EORTC 10994\/BIG 100 study. Eur J Cancer. 2017;79:226\u201334.","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"18057_CR54","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1245\/s10434-015-4697-7","volume":"22","author":"TJ Yang","year":"2015","unstructured":"Yang TJ, Morrow M, Modi S, et al. The Effect of molecular subtype and residual disease on locoregional recurrence in breast cancer patients treated with neoadjuvant chemotherapy and postmastec-tomy radiation. Ann Surg Oncol. 2015;22(Suppl 3):S495\u2013501.","journal-title":"Ann Surg Oncol"},{"key":"18057_CR55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2020.02.015","volume":"130","author":"G Werutsky","year":"2020","unstructured":"Werutsky G, Untch M, Hanusch C, et al. Locoregional recurrence risk after neoadjuvant chemotherapy: a pooled analysis of nine prospective neoadjuvant breast cancer trials. Eur J Cancer. 2020;130:92\u2013101.","journal-title":"Eur J Cancer"},{"key":"18057_CR56","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee SJ, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376:2147\u201359.","journal-title":"N Engl J Med"},{"key":"18057_CR57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380:617\u201328.","journal-title":"N Engl J Med"},{"key":"18057_CR58","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","volume":"391","author":"P Schmid","year":"2024","unstructured":"Schmid P, Cortes J, Dent R, et al. Overall survival with pembrolizumab in early-stage triple negative breast cancer. N Engl J Med. 2024;391:1981\u201391.","journal-title":"N Engl J Med"},{"key":"18057_CR59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317\u201327.","journal-title":"N Engl J Med"},{"key":"18057_CR60","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1200\/JCO.2015.63.6456","volume":"34","author":"LB Thorsen","year":"2016","unstructured":"Thorsen LB, Offersen BV, Dano H, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34:314\u201320.","journal-title":"J Clin Oncol"},{"key":"18057_CR61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ijrobp.2013.03.021","volume":"86","author":"C Hennequin","year":"2013","unstructured":"Hennequin C, Bossard N, Servagi-Vernat S, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2013;86:860\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR62","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamaoncol.2021.6036","volume":"8","author":"YB Kim","year":"2022","unstructured":"Kim YB, Byun HK, Kim DY, et al. Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial. JAMA Oncol. 2022;8:96\u2013105.","journal-title":"JAMA Oncol"},{"key":"18057_CR63","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jamaoncol.2024.2652","volume":"10","author":"JS Wong","year":"2024","unstructured":"Wong JS, Uno H, Tramontano AC, et al. Hypofractionated vs conventionally fractionated postmastectomy radiation after implant-based reconstruction: a randomized clinical trial. JAMA Oncol. 2024;10:1370\u20138.","journal-title":"JAMA Oncol"},{"key":"18057_CR64","first-page":"4705","volume":"20","author":"XB Zhao","year":"2016","unstructured":"Zhao XB, Ren GS. Analysis of radiotherapy optimization regimens after modified radical mastectomy. Eur Rev Med Pharmacol Sci. 2016;20:4705\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"18057_CR65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","volume":"20","author":"SL Wang","year":"2019","unstructured":"Wang SL, Fang H, Song YW, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019;20:352\u201360.","journal-title":"Lancet Oncol"},{"key":"18057_CR66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S1460396919000992","volume":"20","author":"S Maiti","year":"2021","unstructured":"Maiti S, Meyur S, Mandal BC, Shenoi LR, Biswas S, Basu S. Comparison of conventional and hypofractionated radiation after mastectomy in locally advanced breast cancer: a prospective randomised study on dosimetric evaluation and treatment outcome. JRadiot Pract. 2021;20:30\u20138.","journal-title":"JRadiot Pract"},{"key":"18057_CR67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.33525","volume":"149","author":"N Kim","year":"2021","unstructured":"Kim N, Chang JS, Shah C, et al. Hypofractionated volumetric-modulated arc therapy for breast cancer: a propensity-score-weighted comparison of radiation-related toxicity. Int J Cancer. 2021;149:149\u201357.","journal-title":"Int J Cancer"},{"key":"18057_CR68","first-page":"524","volume":"39","author":"HJ Zhang","year":"2018","unstructured":"Zhang HJ, Qu BL, Meng LL, Yu W, Ma L. Clinical observation of short-term efficacies of different hypofractionated radiation therapies after modified radical mastectomy for breast cancer. Eur J Gynaecol Oncol. 2018;39:524\u201332.","journal-title":"Eur J Gynaecol Oncol"},{"key":"18057_CR69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13014-019-1378-x","volume":"14","author":"I Chitapanarux","year":"2019","unstructured":"Chitapanarux I, Klunklin P, Pinitpatcharalert A, et al. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity. Radiat Oncol. 2019;14:175.","journal-title":"Radiat Oncol"},{"key":"18057_CR70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","volume":"9","author":"SM Bentzen","year":"2008","unstructured":"Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofrac-tionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331\u201341.","journal-title":"Lancet Oncol"},{"key":"18057_CR71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2017.10.033","volume":"126","author":"JS Haviland","year":"2018","unstructured":"Haviland JS, Mannino M, Griffin C, et al. Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: results from the UK START (Standardisation of Breast Radiotherapy) trials. Radiother Oncol. 2018;126:155\u201362.","journal-title":"Radiother Oncol"},{"key":"18057_CR72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijrobp.2021.09.031","volume":"112","author":"DY Kim","year":"2022","unstructured":"Kim DY, Park E, Heo CY, et al. Influence of hypofractionated versus conventional fractionated postmastectomy radiation therapy in breast cancer patients with reconstruction. Int J Radiat Oncol Biol Phys. 2022;112:445\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/02841860903352959","volume":"49","author":"O Matzinger","year":"2010","unstructured":"Matzinger O, Heimsoth I, Poortmans P, et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922\/10925). Acta Oncol. 2010;49:24\u201334.","journal-title":"Acta Oncol"},{"key":"18057_CR74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.clbc.2018.07.016","volume":"18","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman O. Impact of regional nodal irradiation on the outcomes of N1 breast cancer patients referred for adjuvant treatment: a patient-level pooled analysis of 2 clinical trials. Clin Breast Cancer. 2018;18:504\u201310.","journal-title":"Clin Breast Cancer"},{"key":"18057_CR75","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2011.02.045","volume":"82","author":"JE Panoff","year":"2012","unstructured":"Panoff JE, Takita C, Hurley J, et al. Higher chest wall dose results in improved locoregional outcome in patients receiving postmastec-tomy radiation. Int J Radiat Oncol Biol Phys. 2012;82:1192\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clbc.2019.04.010","volume":"19","author":"A Albert","year":"2019","unstructured":"Albert A, Mangana S, Nittala MR, Thomas TV, Weatherall L, Vijayakumar S. The impact of a postmastectomy chest wall scar boost on local recurrence-free survival in high-risk patients. Clin Breast Cancer. 2019;19:363\u20139.","journal-title":"Clin Breast Cancer"},{"key":"18057_CR77","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijrobp.2007.03.033","volume":"69","author":"W Marhin","year":"2007","unstructured":"Marhin W, Wai E, Tyldesley S. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys. 2007;69:483\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307\u201316.","journal-title":"N Engl J Med"},{"key":"18057_CR79","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","volume":"41","author":"SAL Bartels","year":"2023","unstructured":"Bartels SAL, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981\u201322023 AMAROS trial. J Clin Oncol. 2023;41:2159\u201365.","journal-title":"J Clin Oncol"},{"key":"18057_CR80","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.22.00044","volume":"40","author":"LBJ Thorsen","year":"2022","unstructured":"Thorsen LBJ, Overgaard J, Matthiessen LW, et al. Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the Danish Breast Cancer Group internal mammary node study. J Clin Oncol. 2022;40:4198\u2013206.","journal-title":"J Clin Oncol"},{"key":"18057_CR81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.breast.2021.01.003","volume":"56","author":"SY Chung","year":"2021","unstructured":"Chung SY, Chang JS, Shin KH, et al. Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: a multi-institutional validation study. Breast. 2021;56:7\u201313.","journal-title":"Breast"},{"key":"18057_CR82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.31557\/APJCP.2020.21.1.119","volume":"21","author":"C Tovanabutra","year":"2020","unstructured":"Tovanabutra C, Katanyoo K, Uber P, Chomprasert K, Sukauichai S. Comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. Asian Pac J Cancer Prev. 2020;21:119\u201325.","journal-title":"Asian Pac J Cancer Prev"},{"key":"18057_CR83","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2010.02.041","volume":"80","author":"EL Stokes","year":"2011","unstructured":"Stokes EL, Tyldesley S, Woods R, Wai E, Olivotto IA. Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80:403\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR84","first-page":"e3","volume":"117","author":"JS Wong","year":"2023","unstructured":"Wong JS, Uno H, Tramountano A, et al. Patient-reported and toxicity results from the FABREC study: a multicenter randomized trial of hypofractionated vs. conventionally fractionated postmastectomy radiation therapy after implant-based reconstruction. IJROBP. 2023;117:e3\u20134.","journal-title":"IJROBP"},{"key":"18057_CR85","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ijrobp.2024.07.002","volume":"120","author":"MM Poppe","year":"2024","unstructured":"Poppe MM, Le-Rademacher J, Haffty BG, et al. A randomized trial of hypofractionated post-mastectomy radiation therapy (PMRT) in women with breast reconstruction (RT CHARM, Alliance A221505). Int J Radiat Oncol Biol Phys. 2024;120:S11.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR86","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2023.09.023","volume":"118","author":"K Diao","year":"2024","unstructured":"Diao K, Lei X, He W, et al. Racial and ethnic differences in long-term adverse radiation therapy effects among breast cancer survivors. Int J Radiat Oncol Biol Phys. 2024;118:626\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR87","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2014.06.042","volume":"90","author":"JL Wright","year":"2014","unstructured":"Wright JL, Takita C, Reis IM, Zhao W, Lee E, Hu JJ. Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2014;90:335\u201343.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.adro.2018.04.013","volume":"3","author":"P Fang","year":"2018","unstructured":"Fang P, He W, Gomez D, et al. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol. 2018;3:221\u20139.","journal-title":"Adv Radiat Oncol"},{"key":"18057_CR89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2017.06.2458","volume":"99","author":"N Ohri","year":"2017","unstructured":"Ohri N, Moshier E, Ho A, et al. Postmastectomy radiation in breast cancer patients with pathologically positive lymph nodes after neo-adjuvant chemotherapy: usage rates and survival trends. Int J Radiat Oncol Biol Phys. 2017;99:549\u201359.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR90","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613\u201326.","journal-title":"Lancet"},{"key":"18057_CR91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","volume":"174","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Chatterjee S. HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results\u2014Interim analysis. Radiother Oncol. 2022;174:59\u201368.","journal-title":"Radiother Oncol"},{"key":"18057_CR92","unstructured":"ClinicalTrials.gov. Hypofractionated LocoRegional Radiotherapy in Breast Cancer (RHEAL). Accessed January 23, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04228991."},{"key":"18057_CR93","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0360-3016(00)00561-7","volume":"47","author":"Z Liao","year":"2000","unstructured":"Liao Z, Strom EA, Buzdar AU, et al. Locoregional irradiation for inflammatory breast cancer: effecuveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys. 2000;47:1191\u2013200.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR94","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","volume":"72","author":"IJ Bristol","year":"2008","unstructured":"Bristol IJ, Woodward WA, Strom EA, et al. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2008;72:474\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR95","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.prro.2022.10.012","volume":"13","author":"JM Purswani","year":"2023","unstructured":"Purswani JM, Oh C, Teruel JR, et al. Definitive radiation with nodal boost for patients with locally advanced breast cancer. Pract Radiat Oncol. 2023;13:e103\u201314.","journal-title":"Pract Radiat Oncol"},{"key":"18057_CR96","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.989466","volume":"13","author":"ST Klusen","year":"2023","unstructured":"Klusen ST, Peiler A, Schmidt GP, et al. Simultaneous integrated boost within the lymphatic drainage system in breast cancer: a single center study on toxicity and oncologic outcome. Front Oncol. 2023;13:989466.","journal-title":"Front Oncol"},{"key":"18057_CR97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clbc.2014.07.005","volume":"15","author":"J Mayadev","year":"2015","unstructured":"Mayadev J, Einck J, Elson S, et al. Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. Clin Breast Cancer. 2015;15:43\u20137.","journal-title":"Clin Breast Cancer"},{"key":"18057_CR98","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clbc.2014.11.007","volume":"15","author":"C Hess","year":"2015","unstructured":"Hess C, Lee A, Fish K, Daly M, Cress RD, Mayadev J. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in Californian women after mastectomy. Clin Breast Cancer. 2015;15:212\u20138.","journal-title":"Clin Breast Cancer"},{"key":"18057_CR99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13014-017-0934-5","volume":"12","author":"S Sachdev","year":"2017","unstructured":"Sachdev S, Goodman CR, Neuschler E, et al. Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer. Radiat Oncol. 2017;12:199.","journal-title":"Radiat Oncol"},{"key":"18057_CR100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijrobp.2021.08.026","volume":"112","author":"K Diao","year":"2022","unstructured":"Diao K, Andring LM, Barcenas CH, et al. Contemporary outcomes after multimodality therapy in patients with breast cancer presenting with ipsilateral supraclavicular node involvement. Int J Radiat Oncol Biol Phys. 2022;112:66\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR101","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1017\/S1460396920000503","volume":"20","author":"E Osei","year":"2021","unstructured":"Osei E, Dang S, Darko J, Fleming K, Rachakonda R. Dosimetric evaluation of 3 and\/or 4 field radiation therapy of breast cancers: clinical experience. J Radiother Pract. 2021;20:380\u201394.","journal-title":"J Radiother Pract"},{"key":"18057_CR102","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2017.01.205","volume":"98","author":"N Grellier Adedjouma","year":"2017","unstructured":"Grellier Adedjouma N, Chevrier M, Fourquet A, et al. Long-term results of a highly performing conformal electron therapy technique for chest wall irradiation after mastectomy. Int J Radiat Oncol Biol Phys. 2017;98:206\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR103","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.prro.2011.07.001","volume":"2","author":"SL Wang","year":"2012","unstructured":"Wang SL, Li YX, Song YW, et al. Postmastectomy chest wall radiotherapy with single low-energy electron beam: an assessment of outcome and prognostic factors. Pract Radiat Oncol. 2012;2:106\u201313.","journal-title":"Pract Radiat Oncol"},{"key":"18057_CR104","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ijrobp.2018.04.075","volume":"101","author":"R Jagsi","year":"2018","unstructured":"Jagsi R, Griffith KA, Moran JM, et al. A randomized comparison of radiation therapy techniques in the management of node-positive breast cancer: primary outcomes analysis. Int J Radiat Oncol Biol Phys. 2018;101:1149\u201358.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-7-80","volume":"7","author":"H Van Parijs","year":"2012","unstructured":"Van Parijs H, Miedema G, Vinh-Hung V, et al. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol. 2012;7:80.","journal-title":"Radiat Oncol"},{"key":"18057_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0041-1726475","volume":"8","author":"A Mehta","year":"2022","unstructured":"Mehta A, Kumar P, Silambarasan NS, Kumar A, Kumar P. Comparison of dosimetric parameters of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in breast cancer patients undergoing adjuvant radiotherapy after modified radical mastectomy. Asian J Oncol. 2022;8:1\u20137.","journal-title":"Asian J Oncol"},{"key":"18057_CR107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3857\/roj.2017.00381","volume":"36","author":"K Rastogi","year":"2018","unstructured":"Rastogi K, Sharma S, Gupta S, Agarwal N, Bhaskar S, Jain S. Dosimetric comparison of IMRT versus 3DCRT for post-mastectomy chest wall irradiation. Radiat Oncol J. 2018;36:71\u20138.","journal-title":"Radiat Oncol J"},{"key":"18057_CR108","first-page":"22331","volume":"9","author":"W Li","year":"2016","unstructured":"Li W, Wang J, Cheng H, Yu X, Ma J. IMRT versus 3D-CRT for post-mastectomy irradiation of chest wall and regional nodes: a population-based cmparison of normal lung dose and radiation pneumonitis. Int J Clin Exp Med. 2016;9:22331\u20137.","journal-title":"Int J Clin Exp Med"},{"key":"18057_CR109","first-page":"437","volume":"9","author":"L Rice","year":"2017","unstructured":"Rice L, Goldsmith C, Green MML, Cleator S, Price PM. An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk. Breast Cancer (Dove Med Press). 2017;9:437\u201346.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"18057_CR110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13014-021-01816-3","volume":"16","author":"S Gaal","year":"2021","unstructured":"Gaal S, Kahan Z, Paczona V, et al. Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility. Radiat Oncol. 2021;16:89.","journal-title":"Radiat Oncol"},{"key":"18057_CR111","first-page":"176","volume":"29","author":"M Laaksomaa","year":"2024","unstructured":"Laaksomaa M, Aula A, Sarudis S, et al. Surface-guided radiotherapy systems in locoregional deep inspiration breath hold radiotherapy for breast cancer\u2014a multicenter study on the setup accuracy. Rep Pract Oncol Radiother. 2024;29:176\u201386.","journal-title":"Rep Pract Oncol Radiother"},{"key":"18057_CR112","volume":"39","author":"LG Sapienza","year":"2023","unstructured":"Sapienza LG, Maia MAC, Gomes MJL, Mattar A, Baiocchi G, Calsavara VF. Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status. Clin Translat Radiat Oncol. 2023;39:100570.","journal-title":"Clin Translat Radiat Oncol"},{"key":"18057_CR113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijrobp.2014.09.022","volume":"91","author":"JP Pignol","year":"2015","unstructured":"Pignol JP, Vu TT, Mitera G, Bosnic S, Verkooijen HM, Truong P. Prospective evaluation of severe skin toxicity and pain during post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2015;91:157\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR114","volume":"7","author":"CFPM de Sousa","year":"2022","unstructured":"de Sousa CFPM, Neto ES, Chen MJ, et al. Postmastectomy radiation therapy bolus associated complications in patients who underwent 2-stage breast reconstruction. Adv Radiat Oncol. 2022;7:101010.","journal-title":"Adv Radiat Oncol"},{"key":"18057_CR115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.clon.2018.03.005","volume":"30","author":"ML Yap","year":"2018","unstructured":"Yap ML, Tieu M, Sappiatzer J, et al. Outcomes in patients treated with post-mastectomy chest wall radiotherapy without the routine use of bolus. Clin Oncol (R Coll Radiol). 2018;30:427\u201332.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"18057_CR116","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.ijrobp.2011.01.002","volume":"81","author":"MT Tieu","year":"2011","unstructured":"Tieu MT, Graham P, Browne L, Chin YS. The effect of adjuvant postmastectomy radiotherapy bolus technique on local recurrence. Int J Radiat Oncol Biol Phys. 2011;81:e165\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR117","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2021.01.019","volume":"110","author":"A Nichol","year":"2021","unstructured":"Nichol A, Narinesingh D, Raman S, et al. The effect of bolus on local control for patients treated with mastectomy and radiation therapy. Int J Radiat Oncol Biol Phys. 2021;110:1360\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR118","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/02841860801975000","volume":"47","author":"MS Thomsen","year":"2008","unstructured":"Thomsen MS, Berg M, Nielsen HM, et al. Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of the Danish Breast Cancer Cooperative Group. Acta Oncol. 2008;47:654\u201361.","journal-title":"Acta Oncol"},{"key":"18057_CR119","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025556","volume":"9","author":"JE Bekelman","year":"2019","unstructured":"Bekelman JE, Lu H, Pugh S, et al. Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-meta-static breast cancer: the radiotherapy comparative effectiveness (RadComp) consortium trial protocol. BMJ Open. 2019;9:e025556.","journal-title":"BMJ Open"},{"key":"18057_CR120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/0284186X.2013.765064","volume":"52","author":"MH Nielsen","year":"2013","unstructured":"Nielsen MH, Berg M, Pedersen AN, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol. 2013;52:703\u201310.","journal-title":"Acta Oncol"},{"key":"18057_CR121","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2019.04.010","volume":"137","author":"O Kaidar-Person","year":"2019","unstructured":"Kaidar-Person O, Vrou Offersen B, Hol S, et al. ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer. Radiother Oncol. 2019;137:159\u201366.","journal-title":"Radiother Oncol"},{"key":"18057_CR122","first-page":"599","volume":"22","author":"J Kagkiouzis","year":"2017","unstructured":"Kagkiouzis J, Platoni K, Kantzou I, et al. Review of the three-field techniques in breast cancer radiotherapy. J Buon. 2017;22:599\u2013605.","journal-title":"J Buon"},{"key":"18057_CR123","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41598-019-39469-8","volume":"9","author":"D Pasquier","year":"2019","unstructured":"Pasquier D, Le Tinier F, Bennadji R, et al. Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life. Sci Rep. 2019;9:2759.","journal-title":"Sci Rep"},{"key":"18057_CR124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12123852","volume":"12","author":"B Bataille","year":"2020","unstructured":"Bataille B, Raoudha B, Le Tinier F, et al. Prospective study of intensity-modulated radiation therapy for locally advanced breast cancer. Cancers. 2020;12:1\u201313.","journal-title":"Cancers"},{"key":"18057_CR125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.617926","volume":"11","author":"JG Bazan","year":"2021","unstructured":"Bazan JG, DiCostanzo D, Hock K, et al. Analysis of radiation dose to the shoulder by treatment technique and correlation with patient reported outcomes in patients receiving regional nodal irradiation. Front Oncol. 2021;11:617926.","journal-title":"Front Oncol"},{"key":"18057_CR126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ctro.2017.09.009","volume":"7","author":"G Lazzari","year":"2017","unstructured":"Lazzari G, Terlizzi A, Leo MG, Silvano G. VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: the incidental effect of low-dose bath exposure. Clin Translat Radiat Oncol. 2017;7:43\u20138.","journal-title":"Clin Translat Radiat Oncol"},{"key":"18057_CR127","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clon.2023.02.015","volume":"35","author":"AM Kirby","year":"2023","unstructured":"Kirby AM, Haviland JS, Mackenzie M, et al. Proton beam therapy in breast cancer patients: the UK PARABLE trial is recruiting. Clin Oncol (R Coll Radiol). 2023;35:347\u201350.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"18057_CR128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2020.10.042","volume":"155","author":"A Yaney","year":"2021","unstructured":"Yaney A, Ayan AS, Pan X, et al. Dosimetric parameters associated with radiation-induced esophagitis in breast cancer patients undergoing regional nodal irradiation. Radiother Oncol. 2021;155:167\u201373.","journal-title":"Radiother Oncol"},{"key":"18057_CR129","first-page":"54","volume":"10","author":"MK Honaryar","year":"2024","unstructured":"Honaryar MK, Locquet M, Allodji R, et al. Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort study. Cardiooncology. 2024;10:54.","journal-title":"Cardiooncology"},{"key":"18057_CR130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meddos.2017.03.003","volume":"42","author":"G Kanyilmaz","year":"2017","unstructured":"Kanyilmaz G, Aktan M, Koc M, Demir H, Demir LS. Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases. Med Dosim. 2017;42:190\u20136.","journal-title":"Med Dosim"},{"key":"18057_CR131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2022.04.052","volume":"115","author":"XR Zhao","year":"2023","unstructured":"Zhao XR, Fang H, Jing H, et al. Radiation-induced hypothyroidism in patients with breast cancer after hypofractionated radiation therapy: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2023;115:83\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR132","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.1994.12.3.447","volume":"12","author":"J Cuzick","year":"1994","unstructured":"Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447\u201353.","journal-title":"J Clin Oncol."},{"key":"18057_CR133","doi-asserted-by":"crossref","unstructured":"Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000;355:1757-1770.","DOI":"10.1016\/S0140-6736(00)02263-7"},{"key":"18057_CR134","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987\u201398.","journal-title":"N Engl J Med"},{"key":"18057_CR135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2020.08.007","volume":"152","author":"E Laugaard Lorenzen","year":"2020","unstructured":"Laugaard Lorenzen E, Christian Rehammar J, Jensen MB, Ewertz M, Brink C. Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977\u20132005. Radio-ther Oncol. 2020;152:103\u201310.","journal-title":"Radio-ther Oncol"},{"key":"18057_CR136","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaccao.2021.07.008","volume":"3","author":"LE Carlson","year":"2021","unstructured":"Carlson LE, Watt GP, Tonorezos ES, et al. Coronary artery disease in young women after radiation therapy for breast cancer: the WECARE study. JACC CardioOncol. 2021;3:381\u201392.","journal-title":"JACC CardioOncol"},{"key":"18057_CR137","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","volume":"35","author":"VA van den Bogaard","year":"2017","unstructured":"van den Bogaard VA, Ta BD, van der Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35:1171\u20138.","journal-title":"J Clin Oncol"},{"key":"18057_CR138","first-page":"39","volume":"19","author":"L Beaton","year":"2019","unstructured":"Beaton L, Bergman A, Nichol A, et al. Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines. Clin Transl Radiat Oncol. 2019;19:39\u201345.","journal-title":"Clin Transl Radiat Oncol"},{"key":"18057_CR139","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-015-3481-5","volume":"152","author":"YC Lee","year":"2015","unstructured":"Lee YC, Chuang JP, Hsieh PC, Chiou MJ, Li CY. A higher incidence rate of acute coronary syndrome following radiation therapy in patients with breast cancer and a history of coronary artery diseases. Breast Cancer Res Treat. 2015;152:429\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"18057_CR140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","volume":"99","author":"MJ Hooning","year":"2007","unstructured":"Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365\u201375.","journal-title":"J Natl Cancer Inst"},{"key":"18057_CR141","doi-asserted-by":"crossref","first-page":"109734","DOI":"10.1016\/j.radonc.2023.109734","volume":"185","author":"MC Aznar","year":"2023","unstructured":"Aznar MC, Carrasco de Fez P, Corradini S, et al. ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy. Radiother Oncol. 2023;185:109734.","journal-title":"Radiother Oncol"},{"key":"18057_CR142","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13014-019-1234-z","volume":"14","author":"S Jacob","year":"2019","unstructured":"Jacob S, Camilleri J, Derreumaux S, et al. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study). Radiat Oncol. 2019;14:29.","journal-title":"Radiat Oncol."},{"key":"18057_CR143","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2021.05.110","volume":"111","author":"RW Mutter","year":"2021","unstructured":"Mutter RW, Choi JI, Jimenez RB, et al. Proton therapy for breast cancer: a consensus statement from the particle therapy cooperative group breast cancer subcommittee. Int J Radiat Oncol Biol Phys. 2021;111:337\u201359.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR144","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ijrobp.2023.02.023","volume":"117","author":"F Holt","year":"2023","unstructured":"Holt F, Probert J, Darby SC, et al. Proton beam therapy for early breast cancer: a systematic review and meta-analysis of clinical outcomes. Int JRadiat Oncol Biol Phys. 2023;117:869\u201382.","journal-title":"Int JRadiat Oncol Biol Phys"},{"key":"18057_CR145","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijrobp.2013.01.038","volume":"86","author":"SM MacDonald","year":"2013","unstructured":"MacDonald SM, Patel SA, Hickey S, et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86:484\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR146","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1200\/JCO.18.02366","volume":"37","author":"RB Jimenez","year":"2019","unstructured":"Jimenez RB, Hickey S, DePauw N, et al. Phase II study of proton beam radiation therapy for patients with breast cancer requiring regional nodal irradiation. J Clin Oncol. 2019;37:2778\u201385.","journal-title":"J Clin Oncol"},{"key":"18057_CR147","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijrobp.2022.08.036","volume":"115","author":"MZO Hassan","year":"2023","unstructured":"Hassan MZO, Awadalla M, Tan TC, et al. Serial measurement of global longitudinal strain among women with breast cancer treated with proton radiation therapy: a prospective trial for 70 patients. Int J Radiat Oncol Biol Phys. 2023;115:398\u2013406.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR148","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/14737140.7.1.89","volume":"7","author":"D Jaffray","year":"2007","unstructured":"Jaffray D, Kupelian P, Djemil T, Macklis RM. Review of image-guided radiation therapy. Expert Rev Anticancer Ther. 2007;7:89\u2013103.","journal-title":"Expert Rev Anticancer Ther"},{"key":"18057_CR149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2008.04.049","volume":"73","author":"AC Hartford","year":"2009","unstructured":"Hartford AC, Palisca MG, Eichler TJ, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College ofRadiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys. 2009;73:9\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"18057_CR150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.prro.2013.01.004","volume":"3","author":"DA Jaffray","year":"2013","unstructured":"Jaffray DA, Langen KM, Mageras G, et al. Safety considerations for IGRT: executive summary. Pract Radiat Oncol. 2013;3:167\u201370.","journal-title":"Pract Radiat Oncol"},{"key":"18057_CR151","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00066-019-01494-x","volume":"195","author":"M Pazos","year":"2019","unstructured":"Pazos M, Walter F, Reitz D, et al. Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients. Strahlenther Onkol. 2019;195:964\u201371.","journal-title":"Strahlenther Onkol"},{"key":"18057_CR152","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13014-018-1072-4","volume":"13","author":"D Reitz","year":"2018","unstructured":"Reitz D, Carl G, Sch\u00f6necker S, et al. Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions. Radiat Oncol. 2018;13:128.","journal-title":"Radiat Oncol."},{"key":"18057_CR153","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2022.05.026","volume":"173","author":"P Freislederer","year":"2022","unstructured":"Freislederer P, Batista V, Ollers M, et al. ESTRO-ACROP guideline on surface guided radiation therapy. Radiother Oncol. 2022;173:188\u201396.","journal-title":"Radiother Oncol"},{"key":"18057_CR154","first-page":"e82","volume":"49","author":"HA Al-Hallaq","year":"2022","unstructured":"Al-Hallaq HA, Cervino L, Gutierrez AN, et al. AAPM task group report 302: Surface-guided radiotherapy. Med Phys. 2022;49:e82\u2013112.","journal-title":"Med Phys"},{"key":"18057_CR155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.prro.2012.09.004","volume":"3","author":"RC Blitzblau","year":"2013","unstructured":"Blitzblau RC, Horton JK. Treatment planning technique in patients receiving postmastectomy radiation therapy. Pract Radiat Oncol. 2013;3:241\u20138.","journal-title":"Pract Radiat Oncol"},{"key":"18057_CR156","volume":"163","author":"HM Dahn","year":"2021","unstructured":"Dahn HM, Boersma LJ, de Ruysscher D, et al. The use of bolus in postmastectomy radiation therapy for breast cancer: a systematic review. CritRev Oncol Hematol. 2021;163:103391.","journal-title":"CritRev Oncol Hematol"},{"key":"18057_CR157","doi-asserted-by":"crossref","unstructured":"Chatterjee S, Chakraborty S, Group HAA. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant) study protocol for a multicentre, randomized phase III trial. Trials. 2020;21:819","DOI":"10.1186\/s13063-020-04751-y"},{"key":"18057_CR158","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/0284186X.2021.1986229","volume":"61","author":"M Fuglsang Jensen","year":"2022","unstructured":"Fuglsang Jensen M, Stick LB, Hoyer M, et al. Proton therapy for early breast cancer patients in the DBCG proton trial: planning, adaptation, and clinical experience from the first 43 patients. Acta Oncol. 2022;61:223\u201330.","journal-title":"Acta Oncol"},{"key":"18057_CR159","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021;74:790\u20139.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"18057_CR160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.","journal-title":"BMJ"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18057-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:40:56Z","timestamp":1760715656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18057-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":160,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["18057"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18057-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"16 September 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All task force members' disclosure statements were reviewed before being invited and were shared with other task force members throughout the guideline's development. Those disclosures are published within this guideline. Where potential conflicts were detected, remedial measures to address them were taken.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited. Adherence to this guideline does not ensure successful treatment in every situation. This guideline should not be deemed inclusive of all proper methods of care or of all factors influencing the treatment decision, nor is it intended to be exclusive of other methods reasonably directed to obtaining the same results. ASTRO assumes no liability for the information, conclusions, and findings contained in its guidelines. This guideline cannot be assumed to apply to the use of these interventions performed in the context of clinical trials. This guideline is based on information available at the time the task force conducted its research and discussions on this topic. There may be new developments that are not reflected in this guideline and that may, over time, be a basis for ASTRO to revisit and update the guideline.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer and Adherence"}}]}}